The involvement of glucose metabolism in the regulation of inducible nitric oxide synthase gene expression in glial cells: possible role of glucose-6-phosphate dehydrogenase and CCAAT/enhancing binding protein

J Neurosci. 2003 Aug 20;23(20):7470-8. doi: 10.1523/JNEUROSCI.23-20-07470.2003.

Abstract

In rat glial cells the lipopolysaccharide (LPS)-induced inducible nitric oxide synthase (iNOS) gene expression was enhanced by extracellular glucose concentration in a dose-dependent manner. On the other hand, 2-deoxy-d-glucose decreased the LPS-induced iNOS gene expression even in the presence of glucose (6 gm/l), suggesting that glucose metabolism is linked to the regulation of iNOS gene expression. The intracellular NADPH/NADP+ directly correlated with the extracellular glucose concentration, and the reduction of NADPH generation via a block of glucose-6-phosphate dehydrogenase (G6PD) by treatment with dehydroepiandrosterone or the antisense DNA oligomer of G6PD mRNA resulted in the inhibition of iNOS gene expression. Gel shift assays showed that CAAT/enhancing binding protein (C/EBP), rather than AP-1 or NF-kappaB, correlated better with a glucose-dependent increase in iNOS gene expression. The induction of C/EBP DNA binding activity by LPS and glucose was attributable mainly to the increase in C/EBP-delta protein. The cotransfection with wild-type C/EBP-delta increased the iNOS promoter activity to the level achieved with a higher glucose concentration in the presence of LPS. Therefore, our results suggest that C/EBP-delta may be a critical mediator in glucose-mediated regulation of iNOS gene expression.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Astrocytes / drug effects
  • Astrocytes / metabolism
  • CCAAT-Enhancer-Binding Protein-delta
  • CCAAT-Enhancer-Binding Proteins / physiology*
  • Cells, Cultured
  • Dehydroepiandrosterone / pharmacology
  • Glucose / metabolism
  • Glucose / pharmacology*
  • Glucose / toxicity
  • Glucosephosphate Dehydrogenase / physiology*
  • Lipopolysaccharides / pharmacology
  • Monomeric GTP-Binding Proteins / metabolism
  • NADP / metabolism
  • NF-kappa B / metabolism
  • Neuroglia / drug effects
  • Neuroglia / enzymology*
  • Neuroglia / metabolism
  • Nitric Oxide / biosynthesis
  • Nitric Oxide Synthase / biosynthesis
  • Nitric Oxide Synthase / genetics*
  • Nitric Oxide Synthase Type II
  • Rats
  • Response Elements
  • Transcription Factor AP-1 / metabolism
  • Transcription Factors*
  • Transcriptional Activation
  • Tumor Cells, Cultured

Substances

  • CCAAT-Enhancer-Binding Proteins
  • Cebpd protein, rat
  • Lipopolysaccharides
  • NF-kappa B
  • Transcription Factor AP-1
  • Transcription Factors
  • CCAAT-Enhancer-Binding Protein-delta
  • Nitric Oxide
  • Dehydroepiandrosterone
  • NADP
  • Adenosine Triphosphate
  • Glucosephosphate Dehydrogenase
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Monomeric GTP-Binding Proteins
  • Glucose